View Item 

Show simple item record

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
dc.contributor.authorLenk, Guy M.
dc.contributor.authorJafar‐nejad, Paymaan
dc.contributor.authorHill, Sophie F.
dc.contributor.authorHuffman, Lucas D.
dc.contributor.authorSmolen, Corrine E.
dc.contributor.authorWagnon, Jacy L.
dc.contributor.authorPetit, Hayley
dc.contributor.authorYu, Wenxi
dc.contributor.authorZiobro, Julie
dc.contributor.authorBhatia, Kritika
dc.contributor.authorParent, Jack
dc.contributor.authorGiger, Roman J.
dc.contributor.authorRigo, Frank
dc.contributor.authorMeisler, Miriam H.
dc.date.accessioned2020-03-17T18:29:37Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-03-17T18:29:37Z
dc.date.issued2020-03
dc.identifier.citationLenk, Guy M.; Jafar‐nejad, Paymaan ; Hill, Sophie F.; Huffman, Lucas D.; Smolen, Corrine E.; Wagnon, Jacy L.; Petit, Hayley; Yu, Wenxi; Ziobro, Julie; Bhatia, Kritika; Parent, Jack; Giger, Roman J.; Rigo, Frank; Meisler, Miriam H. (2020). "Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome." Annals of Neurology 87(3): 339-346.
dc.identifier.issn0364-5134
dc.identifier.issn1531-8249
dc.identifier.urihttps://hdl.handle.net/2027.42/154348
dc.publisherJohn Wiley & Sons, Inc.
dc.titleScn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPsychiatry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154348/1/ana25676.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154348/2/ana25676_am.pdf
dc.identifier.doi10.1002/ana.25676
dc.identifier.sourceAnnals of Neurology
dc.identifier.citedreferenceKearney JA, Buchner DA, de Haan G, et al. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Nav1.6). Hum Mol Genet 2002; 11: 2765 â 2775.
dc.identifier.citedreferenceWagnon JL, Barker BS, Hounshell JA, et al. Pathogenic mechanisms of recurrent epileptogenic mutations of SCN8A in epileptic encephalopathy. Ann Clin Transl Neurol 2016; 3: 114 â 123.
dc.identifier.citedreferenceWagnon J, Meisler MH. Recurrent and nonâ recurrent mutations of SCN8A in epileptic encephalopathy. Front Neurol 2015; 6: 104.
dc.identifier.citedreferenceLiu Y, Schubert J, Sonnenberg L, et al. Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability. Brain 2019; 142: 376 â 390.
dc.identifier.citedreferenceBuntonâ Stasyshyn RKA, Wagnon JL, Wengert ER, et al. Prominent role of forebrain excitatory neurons in SCN8A encephalopathy. Brain 2019; 142: 362 â 375.
dc.identifier.citedreferenceSouthwell AL, Kordasiewicz HB, Langbehn D, et al. Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease. Sci Transl Med 2018; 10: eaar3959.
dc.identifier.citedreferenceMcCampbell A, Cole T, Wegener AJ, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest 2018; 128: 3558 â 3567.
dc.identifier.citedreferenceBennett CF. Therapeutic antisense oligonucleotides are coming of age. Annu Rev Med 2019; 70: 307 â 321.
dc.identifier.citedreferenceRoovers J, De Jonghe P, Weckhuysen S. The therapeutic potential of RNA regulation in neurological disorders. Expert Opin Ther Targets 2018; 22: 1017 â 1028.
dc.identifier.citedreferenceBennett CF, Krainer AR, Cleveland D. Antisense oligonucleotide therapies for neurodegenerative disorders. Ann Rev Neurosci 2019; 42: 385 â 406.
dc.identifier.citedreferenceFinkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantileâ onset spinal muscular atrophy. N Engl J Med 2017; 377: 1723 â 1732.
dc.identifier.citedreferenceMiller AR, Hawkins NA, McCollom CE, Kearney JA. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. Genes Brain Behav 2014; 13: 163 â 172.
dc.identifier.citedreferenceSwayze EE, Siwkowski AM, Wancewicz EV, et al. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 2007; 35: 687 â 700.
dc.identifier.citedreferenceBecker LA, Huang B, Bieri G, et al. Therapeutic reduction of ataxinâ 2 extends lifespan and reduces pathology in TDPâ 43 mice. Nature 2017; 544: 367 â 371.
dc.identifier.citedreferenceDuan Y, Wang SH, Song J, et al. Semaphorin 5A inhibits synaptogenesis in early postnatalâ and adultâ born hippocampal dentate granule cells. Elife 2014; 3: e04390.
dc.identifier.citedreferenceSchmittgen TD, Livak KJ. Analyzing realâ time PCR data by the comparative CT method. Nat Protoc 2008; 3: 1101 â 1108.
dc.identifier.citedreferenceWagnon JL, Korn MJ, Parent R, et al. Convulsive seizures and SUDEP in a mouse model of SCN8A related epileptic encephalopathy. Human Molec Genet 2015; 24: 506 â 515.
dc.identifier.citedreferenceBurgess DL, Kohrman DC, Galt J, et al. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant ’motor endplate disease’. Nat Genet 1995; 10: 461 â 465.
dc.identifier.citedreferenceSprunger LK, Escayg A, Tallaksenâ Greene S, et al. Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3. Hum Mol Genet 1999; 8: 471 â 479.
dc.identifier.citedreferenceMcKinney BC, Chow CY, Meisler MH, Murphy GG. Exaggerated emotional behavior in mice heterozygous for the sodium channel Scn8a (Na(v)1.6). Genes Brain Behav 2008; 7: 629 â 638.
dc.identifier.citedreferenceWagnon JL, Barker BS, Ottolini M, et al. Lossâ ofâ function variants of SCN8A in intellectual disability without seizures. Neurol Genet 2017; 3: e170.
dc.identifier.citedreferenceMøller R, Wengert ER, Tronhjem CE, et al. Biallelic variants of SCN8A with reduced channel activity in two families with developmental and epileptic encephalopathy. Epilepsia 2019; 60: 2277 â 2285.
dc.identifier.citedreferenceGuyenet SJ, Furrer SA, Damian VM, et al. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp 2010; 39: 1787.
dc.identifier.citedreferenceIsom LL. Is targeting of compensatory ion channel gene expression a viable therapeutic strategy for Dravet syndrome? Epilepsy Curr 2019; 19: 193 â 195.
dc.identifier.citedreferenceWong JC, Makinson CD, Lamar T, et al. Selective targeting of Scn8a prevents seizure development in a mouse model of mesial temporal lobe epilepsy. Sci Rep 2018; 8: 126.
dc.identifier.citedreferenceMartin MS, Tang B, Papale LA, et al. The voltageâ gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum Mol Genet 2007; 16: 2892 â 2899.
dc.identifier.citedreferenceFavero M, Sotuyo NP, Lopez E, et al. A transient developmental window of fastâ spiking interneuron dysfunction in a mouse model of Dravet syndrome. J Neurosci 2018; 38: 7912 â 7927.
dc.identifier.citedreferenceBerg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005â 2009. Epilepsia 2010; 51: 676 â 685.
dc.identifier.citedreferenceScheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 512 â 521.
dc.identifier.citedreferenceMeisler MH, Kearney KJ. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 2005; 115: 2010 â 2017.
dc.identifier.citedreferenceLarsen J, Carvill GL, Gardella E, et al. The phenotypic spectrum of SCN8A encephalopathy. Neurology 2015; 84: 480 â 489.
dc.identifier.citedreferenceLindy AS, Stosser MB, Butler E, et al. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders. Epilepsia 2018; 59: 1062 â 1071.
dc.identifier.citedreferenceMeisler MH, Helman G, Hammer MF, et al. SCN8A encephalopathy: research progress and prospects. Epilepsia 2016; 57: 1027 â 1035.
dc.identifier.citedreferenceGardella E, Marini C, Trivisano M, et al. The phenotype of SCN8A developmental and epileptic encephalopathy. Neurology 2018; 91: e1112 â e1124.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ana25676.pdf
Size:
1.620MB
Format:
PDF
View/Open
Name:
ana25676_am.pdf
Size:
4.380MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.